CULLINAN THERAPEUTICS, INC. (CGEM) Return on equity 2020–2022
CULLINAN THERAPEUTICS, INC. (CGEM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
20.8%FY2022 · since FY2020: -26.0% → 20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 20.8% | +36.2 pp |
| FY2021 | -15.4% | +10.6 pp |
| FY2020 | -26.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice